CereVasc
- Total Funding
- $198.9M
- Last Round
- $85.0M Series CJun 2026
- Rounds
- 3
About
Medical device company developing the eShunt system for normal pressure hydrocephalus treatment.
Summary
CereVasc is a Healthcare company based in United States. It has raised $198.9M in total across 3 rounds, most recently a $85.0M Series C round in Jun 2026. Investors include Bain Capital Life Sciences and Perceptive Advisors.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Jun 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Similar Companies
operates in the healthcare industry focusing on biotechnology business
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...